Showing results (51-60 of 209) with videos related to
Sort By:
Pageof 21
Seminars in Vascular Medicine|June 17, 2004
Venous thromboembolic disease: risk factors and laboratory investigationM Alhenc-Gelas, M Aiach, P de MoerlooseHaemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2016
Rare coagulation disorders: fibrinogen, factor VII and factor XIIIP de Moerloose, J-F Schved, D NugentBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1996
Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbsH Bounameaux, P de Moerloose, F P SarasinJournal of Thrombosis and Haemostasis : JTH|January 20, 2016
Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control studyT Marchetti, P de Moerloose, J C GrisClinical and Experimental Rheumatology|November 1, 1990
Anticardiolipin antibody determination: comparison of three ELISA assaysP De Moerloose, G Reber, J J VogelDie Pharmazie|October 1, 1986
Chromatographic isolation and mass spectrometric identification of a base-induced mebendazole fluorophorW Baeyens, F Abdel Fattah, P De MoerlooseJournal of Pharmaceutical Sciences|December 1, 1977
Fluorescence characteristics of azaperone and of an azaperone mononitrogen oxideW Baeyens, P De Moerloose, L De TaeyeThrombosis Research|June 1, 1991
Laboratory and clinical features in systemic lupus erythematosus patients with or without anticardiolipin antibodiesJ J Vogel, G Reber, P de MoerlooseSeminars in Thrombosis and Hemostasis|October 8, 1998
The place of D-dimer testing in an integrated approach of patients suspected of pulmonary embolismP de Moerloose, J J Michiels, H BounameauxRevue Medicale Suisse|March 28, 2006
[Anticoagulation in patients with chronic renal failure]L Niksic, P Saudan, F BoehlenPageof 21